FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2300533671> ?p ?o ?g. }

• W2300533671 abstract "Fertility-sparing surgery for patients with borderline ovarian tumors (BOTs) is still controversial. This study aimed to evaluate the oncological safety and fertility benefits in conservative surgery,as well as efficiency of surgical procedures and approaches.In total 122 patients with BOTs, four types of fertility-sparing surgery were performed: unilateral adnexectomy (UA, n = 47), unilateral cystectomy (UC, n = 59), unilateral adnexectomy + contralateral cystectomy (UA + CC, n = 7) and bilateral cystectomy (BC, n = 9). Fifty-two (42.6 %) patients had undergone laparoscopy, while 70 (57.4 %) had undergone laparotomy. After a median follow-up of 58.0 months, eight patients (6.6 %) relapsed in average of 25.9 months. Only one patient progressed to invasive cancer. None died within our observational period. Univariate analysis showed that patients with elevated CA125, bilateral tumors, extra-ovary tumor or mucinous type tended to replase in shorter time (p < 0.05). Among all cases, 45 patients attempted to conceive and 34 (75.6 %) patients had successful pregnancy. The recurrence rates were successively increased (2.1 %, 6.8 %, 14.3 %, and 22.2 %), the recurrence interval were shortened (48.0, 25.3, 26.0 and 21.2 months) and the subsequent fertility rates were 76.9 %, 77.3 %, 66.7 % and 71.4 % in UA, UC, UA + CC, and BC groups, respectively. As for surgical approaches, three patients (5.8 %) relapsed in 26.3 months in the laparoscopy group and five (7.1 %) in 25.5 months in the laparotomy group. The subsequent fertility rate was higher in laparoscopy group (88.9 %) than in laparotomy group (66.7 %). In our study, 38 patients underwent staging surgery. Two patients (5.3 %) recurrent in average of 21.0 months, and the subsequent pregnancy rate of staging surgery group was 61.5 %. Twelve patients received adjuvant chemotherapy but they didn't get any benefit from it, both in term of recurrence (8.3 %, 26.0 months) and subsequent pregnancy rate (75.5 %).Fertility-sparing surgery is safe and beneficial for most young BOTs. UA through laparoscopy should be recommended as the first choice. To the patients with bilateral tumors, elevated CA125, extra-ovary tumor or mucinous type, conservative surgery should be carefully chosen and subsequent pregnancy should be attempted in short term. In addition, the benefit of comprehensive surgical staging is to be further investigated and adjuvant chemotherapy is not recommended." @default.
• W2300533671 created "2016-06-24" @default.
• W2300533671 creator A5009958266 @default.
• W2300533671 creator A5027835055 @default.
• W2300533671 creator A5032416505 @default.
• W2300533671 creator A5037307308 @default.
• W2300533671 creator A5077682370 @default.
• W2300533671 date "2016-03-18" @default.
• W2300533671 modified "2023-10-16" @default.
• W2300533671 title "Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience" @default.
• W2300533671 cites W1965380539 @default.
• W2300533671 cites W1971447016 @default.
• W2300533671 cites W1975061086 @default.
• W2300533671 cites W1977303055 @default.
• W2300533671 cites W1982436558 @default.
• W2300533671 cites W1998410385 @default.
• W2300533671 cites W1998481399 @default.
• W2300533671 cites W1999708816 @default.
• W2300533671 cites W2003447400 @default.
• W2300533671 cites W2011136145 @default.
• W2300533671 cites W2028605700 @default.
• W2300533671 cites W2037788970 @default.
• W2300533671 cites W2039704180 @default.
• W2300533671 cites W2045071359 @default.
• W2300533671 cites W2046189688 @default.
• W2300533671 cites W2056355224 @default.
• W2300533671 cites W2066431581 @default.
• W2300533671 cites W2071605994 @default.
• W2300533671 cites W2093650348 @default.
• W2300533671 cites W2112043155 @default.
• W2300533671 cites W2123014902 @default.
• W2300533671 cites W2145880664 @default.
• W2300533671 cites W2148877092 @default.
• W2300533671 cites W2153780770 @default.
• W2300533671 cites W2154736233 @default.
• W2300533671 cites W2167163678 @default.
• W2300533671 cites W2170629197 @default.
• W2300533671 cites W2171879623 @default.
• W2300533671 cites W2216145472 @default.
• W2300533671 cites W2333901487 @default.
• W2300533671 cites W2408988026 @default.
• W2300533671 cites W2469156655 @default.
• W2300533671 doi "https://doi.org/10.1186/s13048-016-0226-y" @default.
• W2300533671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4797121" @default.
• W2300533671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26988551" @default.
• W2300533671 hasPublicationYear "2016" @default.
• W2300533671 type Work @default.
• W2300533671 sameAs 2300533671 @default.
• W2300533671 citedByCount "30" @default.
• W2300533671 countsByYear W23005336712016 @default.
• W2300533671 countsByYear W23005336712017 @default.
• W2300533671 countsByYear W23005336712018 @default.
• W2300533671 countsByYear W23005336712019 @default.
• W2300533671 countsByYear W23005336712020 @default.
• W2300533671 countsByYear W23005336712021 @default.
• W2300533671 countsByYear W23005336712022 @default.
• W2300533671 countsByYear W23005336712023 @default.
• W2300533671 crossrefType "journal-article" @default.
• W2300533671 hasAuthorship W2300533671A5009958266 @default.
• W2300533671 hasAuthorship W2300533671A5027835055 @default.
• W2300533671 hasAuthorship W2300533671A5032416505 @default.
• W2300533671 hasAuthorship W2300533671A5037307308 @default.
• W2300533671 hasAuthorship W2300533671A5077682370 @default.
• W2300533671 hasBestOaLocation W23005336711 @default.
• W2300533671 hasConcept C121608353 @default.
• W2300533671 hasConcept C126322002 @default.
• W2300533671 hasConcept C141071460 @default.
• W2300533671 hasConcept C2775910329 @default.
• W2300533671 hasConcept C2777904497 @default.
• W2300533671 hasConcept C2780047204 @default.
• W2300533671 hasConcept C2780352672 @default.
• W2300533671 hasConcept C2780778865 @default.
• W2300533671 hasConcept C2908647359 @default.
• W2300533671 hasConcept C518429986 @default.
• W2300533671 hasConcept C71924100 @default.
• W2300533671 hasConcept C99454951 @default.
• W2300533671 hasConceptScore W2300533671C121608353 @default.
• W2300533671 hasConceptScore W2300533671C126322002 @default.
• W2300533671 hasConceptScore W2300533671C141071460 @default.
• W2300533671 hasConceptScore W2300533671C2775910329 @default.
• W2300533671 hasConceptScore W2300533671C2777904497 @default.
• W2300533671 hasConceptScore W2300533671C2780047204 @default.
• W2300533671 hasConceptScore W2300533671C2780352672 @default.
• W2300533671 hasConceptScore W2300533671C2780778865 @default.
• W2300533671 hasConceptScore W2300533671C2908647359 @default.
• W2300533671 hasConceptScore W2300533671C518429986 @default.
• W2300533671 hasConceptScore W2300533671C71924100 @default.
• W2300533671 hasConceptScore W2300533671C99454951 @default.
• W2300533671 hasFunder F4320321001 @default.
• W2300533671 hasIssue "1" @default.
• W2300533671 hasLocation W23005336711 @default.
• W2300533671 hasLocation W23005336712 @default.
• W2300533671 hasLocation W23005336713 @default.
• W2300533671 hasLocation W23005336714 @default.
• W2300533671 hasOpenAccess W2300533671 @default.
• W2300533671 hasPrimaryLocation W23005336711 @default.
• W2300533671 hasRelatedWork W16047722 @default.
• W2300533671 hasRelatedWork W1993508486 @default.
• W2300533671 hasRelatedWork W2169511669 @default.
• W2300533671 hasRelatedWork W2348951459 @default.

• next